Computational methods for prediction of metabolism of physiologically active substances

Biomeditsinskaya Khimiya

Volumn 51, Issue 4, 2005, Pages 384-412

  Balakin, K V ^a   Ivanenkov, Y A ^a  

^a Chemical Diversity Research Institute   (Russian Federation)

Author keywords

Cytochromes P450; Metabolic enzymes; Metabolic reactions; Metabolic stability; Metabolism prediction; Quantitative structure metabolism relationship (QSMR) modeling

Indexed keywords

XENOBIOTIC AGENT;

ANIMAL; BIOLOGY; BIOTRANSFORMATION; CHEMICAL STRUCTURE; CHEMISTRY; FACTUAL DATABASE; METABOLISM; METHODOLOGY; PROGNOSIS; REVIEW;

ANIMALS; BIOTRANSFORMATION; COMPUTATIONAL BIOLOGY; DATABASES, FACTUAL; MOLECULAR STRUCTURE; PROGNOSIS; XENOBIOTICS;

EID: 27344454728     PISSN: 23106905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (152)

1. Erhardt P.W. (1999) in: Drug metabolism: Drug metabolism data: past, present and future considerations (P.W. Erhardt ed.) Blackwell Science, pp. 17-22.
2. rd., Ferre R.A. (2003) J. Med. Chem., 46, 4572-4585.
3. Tagat J.R., Steensma R.W., McCombie S.W., Nazareno D.V., Lin S.I., Neustadt B.R., Cox K., Xu S., Wojcik L., Murray M.G., Vantuno N., Baroudy B.M., Strizki J.M. (2001) J. Med. Chem., 44, 3343-3346.
4. Palani A., Shapiro S., Josien H., Bara T., Clader J.W., Greenlee W.J., Cox K., Strizki J.M., Baroudy B.M. (2002) J. Med. Chem., 45, 3143-3160.
5. Humphreys W.G., Obermeier M.T., Barrish J.C., Chong S., Marino A.M., Murugesan N., Wang-Iverson D., Morrison R.A. (2003) Xenobiotica, 33, 1109-1123.
6. Burgey C.S., Robinson K.A., Lyle T.A., Sanderson P.E.J., Lewis D.S., Lucas B.J., Krueger J.A., Singh R., Miller-Stein C., White R.B., Wong B. (2003) J. Med. Chem., 46, 461-473.
7. Clader J.W. (2004) J. Med. Chem., 47, 1-9.
8. Bell I.M., Gallicchio S.N., Abrams M., Beese L.S., Beshore D.C., Bhimnathwala H., Bogusky M.J., Buser C.A., Culberson J.C., Davide J., Ellis-Hutchings M. (2002) J. Med. Chem., 45, 2388-2409.
9. Higuchi T., Stella V. (1975) Pro-drugs as novel drug delivery systems, Am. Chem. Soc., Washington.
10. Stella V.J., Himmelstein K.J. (1980) J. Med. Chem., 23, 1275-1282.
11. Deutsch H.M., Glinski J.A., Hernandez M., Haugwitz R.D., Narayanan V.L., Suffness M., Zalkow L.H. (1989) J. Med. Chem. 32, 788-792.
12. Erhardt P.W. (1993) Chronicles Drug Discov., 3, 191-206.
13. Testa B., Jenner P. (1976) Drug Metabolism-Chemical and Biochemical Aspects, Marcel Dekker Inc., New York.
14. Ioannides C. (1996) Cytochromes P450 Metabolic and Toxicological Aspects, CRC Press Inc., New York.
15. Lewis D.F.V. (1996) Cytochromes P450, Taylor & Francis Inc., Bristol.
16. Cashman J.R. (2000) Curr. Drug Metab., 1(2), 181-191.
17. Benedetti M.S., Tipton K.F. (1998) J. Neural Transm. Suppl., 52, 149-171.
18. Yin S.-J., Han C.-Li, Lee A.-I., Wu C.-W. (1999) Adv. Exp. Med. Biol., 463, 265-274.
19. Vasiliou V., Pappa A., Petersen D.R. (2000) Chem.-Biol. Interact., 129(1-2), 1-19.
20. Kitamura S., Nakatani K., Ohashi K., Sugihara K., Hosokawa R., Akagawa Y., Ohta S. (2001) Biol. Pharm. Bull., 24(7), 856-859.
21. Pritsos C.A. (2000) Chem.-Biol. Interact., 129(1-2), 195-208.
22. Armstrong R.N. (1997) Chem. Res. Toxicol., 10, 2-18.
23. Vereczkey L., Jemnitz K., Gregus Z. (1998) Acta. Pharm. Hung., 68(5), 284-288.
24. Negishi M., Pedersen L.G., Petrotchenko E., Shevtsov S., Gorokhov A., Kakuta Y., Pedersen L.C. (2001) Arch. Biochem. Biophys., 390(2), 149-157.
25. Ilett K.F., Kadlubar F.F., Minchin R.F. (1999) Drug Metab. Dispos., 27(9), 957-959.
26. Burchell B., Brierly C.H., Rance D. (1995) Life Sci., 57, 1819-1831.
27. Weinshilboum R. (1989) Pharmacol. Ther., 43, 77-90.
28. Ferrero J.L., Brendel K. (1997) Adv. Pharmacol., 43, 131-169.
29. Fisher R.L., Ulreich J.B., Nakazato P.Z., Brendel K. (2001) Toxicol. Methods, 11(2), 59-79.
30. Vanhulle V.P., Martiat G.A., Verbeeck R.K., Horsmans Y., Calderon P.B., Eeckhoudt S.L., Taper H.S., Delzenne N. (2001) Life Sci., 68(21), 2391-2403.
31. Ekins S., Ring B.J., Grace J., McRobie-Belle D.J., Wrighton S.A. (2000) J. Pharm. Toxicol. Methods, 44(1), 313-324.
32. Cross D.M., Bayliss M.K. (2000) Drug Metab. Rev., 32(2), 219-240.
33. Guillouzo A., Rialland L., Fautrel A., Guyomard C. (1999) Chem.-Biol. Interact., 121(1), 7-16.
34. Li A.P. (1999) Chem.-Biol. Interact., 121(1), 1-5.
35. Umehara K., Kudo S., Hirao Y., Morita S., Uchida M., Odomi M., Miyamoto G. (2000) Drug Metab. Dispos., 28(8), 887-894.
36. Crespi C.L. (1999) Curr. Opin. Drug Discov. Dev., 2(1), 15-19.
37. Caldwell G.W., Masucci J.A., Chacon E. (1999) Comb. Chem. High Throughp. Scr., 2(1), 39-51.
38. Watt A.P., Morrison D., Evans D.C. (2000) Drug Discovery Today, 5(1), 17-24.
39. White R.E. (2000) Annu. Rev. Pharm. Toxicol., 40, 133-157.
40. Cox K.A., Clarke N.J., Rindgen D., Korfmacher W.A. (2001) Am. Pharm. Rev., 4(1), 45-46.
41. Zhou L., Thakker D.R., Voyksner R.D., Anbazhagan M., Boykin D.W., Hall J.E., Tidwell R.R. (2004) J. Mass Spectrom., 39(4), 351-360.
42. Yu X., Cui D., Davis M.R. (1999) J. Am. Soc. Mass Spectrom., 10(2), 175-183.
43. Lopez L.L., Yu X., Cui D., Davis M.R. (1998) Rapid Commun. Mass Spectrom., 12(22), 1756-1760.
44. Fernandez-Metzler C.L., Owens K.G., Baillie T.A., King R.C. (1999) Drug Metab. Dispos., 27(1), 32-40.
45. Owens K.G. (1991) Appl. Spectrosc. Rev., 27(1), 1-49.
46. Van Breemen R.B., Nikolic D., Bolton J.L. (1998) Drug Metab. Dispos., 26(2), 85-90.
47. Nikolic D., Fan P.W., Bolton J.L., Van Breemen R.B. (1999) Comb. Chem. High Throughp., Scr. 2(3), 165-175.
48. Nikolic D., Habibi-Goudarzi S., Corley D.G., Gafner S., Pezzuto J.M., Van Breemen R.B. (2000) Anal. Chem., 72(16), 3853-3859.
49. Wilson I.D., Nicholson J.K., Lindon J.C. (1999) in: Handbook of Drug Metabolism: The role of nuclear magnetic resonance spectroscopy in drug metabolism (T.F. Woolf ed.) Marcel Dekker Inc., New York, pp. 523-550.
50. Dear G.J., Plumb R.S., Sweatman B.C., Parry P.S., Roberts A.D., Lindon J.C., Nicholson J.K., Ismail I.M. (2000) J. Chromatogr.; B: Biomed. Sci. Appl., 748(1), 295-309.
51. Dear G.J., Plumb R.S., Sweatman B.C., Ayrton J., Lindon J.C., Nicholson J.K., Ismail I.M. (2000) J. Chromatogr.; B: Biomed. Sci. Appl., 748(1), 281-293.
52. Lindon J.C., Nicholson J.K., Wilson I.D. (2000) J. Chromatogr.; B: Biomed. Sci. Appl., 748(1), 233-258.
53. Erhardt P.W. (2002) in: High-throughput ADMETox estimation (F. Darvas and G. Dorman eds.) BioTechniques Press, pp. 49-68.
54. MDL Information Systems, Inc. http://www.mdl.com.
55. Erhardt P.W. (2002) in: High-throughput ADMETox estimation: Metabolism Prediction (F. Darvas and G. Dorman eds.) BioTechniques Press, Eaton Publishing, pp. 41-48.
56. Accelrys. Inc.; http://www.accelrys.com.
57. Darvas F. (1987) in: QSAR Environmental Toxicology II: MetabolExpert: an expert system for predicting the metabolism of substances (K.L. Kaiser ed.) Reidel Co., Dordrecht, pp. 71-81.
58. Darvas F.J (1988) Mol. Graphics, 6, 80-86.
59. Klopman G., Dimayuga M., Talafous J. (1994) J. Chem. Inf. Comput. Sci., 34, 1320-1325.
60. Talafous J., Sayre L.M., Mieyal J.J., Klopman G. (1994) J. Chem. Inf. Comput. Sci., 34, 1326-1333.
61. Klopman G., Tu M., Talafous J. (1997) J. Chem. Inf. Comput. Sci., 37, 329-334.
62. Greene N. (1999) Drug Metabolism (P.W. Erhardt ed.) Blackwell Science, pp. 289-296.
63. MetaDrug database, GeneGo, Inc.; http://www.genego.com.
64. Klopman G., Tu M. (1999) in: Drug Metabolism: META: a program for the prediction of the product of mammal metabolism of xenobiotics (P.W. Erhardt ed.) Blackwell Science, pp. 271-276.
65. Klopman G., Li J.-Y., Wang S., Dimayuga, M. (1994) J. Chem. Inf. Comp. Sci., 34, 752-781.
66. Smith D.A., van de Waterbeemd H., Walker D.K. (2001) in: Pharmacokineics and Metabolism in Drug Design: Renal Clearance (D.A. Smith, H. van de Waterbeemd and D.K. Walker eds.) Wiley-VCH, Weinheim, pp. 67-74.
67. Boyer S., Zamora I. (2002) J. Comp.-Aid. Mol. Des., 16(5-6), 403-413.
68. Borodina Yu., Rudik A., Filimonov D., Kharchevnikova N., Dmitriev A., Blinova V., Poroikov V. (2004) J. Chem. Inform. Comput. Sci., 44 (6), 1998-2009.
69. Button W.G., Judson P.N., Long A., Vessey J.D. (2003) J. Chem. Inf. Comp. Sci., 43(5), 1371-1377.
70. Gombar V.K., Silver I.S., Zhao Z. (2003) Curr. Top. Med. Chem., 3(11), 1205-1225.
71. Masimirembwa C.M., Bredberg U., Andersson T.B. (2003) Clin. Pharmacokinet., 42(6), 515-528.
72. Ekins S. (2003) Biochem. Soc. Trans., 31, 611-614.
73. Cruciani G., Meniconi M., Carosati E., Zamora I., Mannhold R. (2003) in: Drug Bioavailability: VOLSURF: a tool for drug ADME-properties prediction (H.van de Waterbeemd, H. Lennernäs and P. Artursson eds.) Wiley-VCH, pp. 406-419.
74. Jolliffe I.T. (2002) Principal Component Analysis, 2nd edition, Springer-Verlag, New York.
75. Shen M., Xiao Y., Golbraikh A., Gombar V.K., Tropsha A. (2003) J. Med. Chem., 46, 3013-3020.
76. Quincy M.A. (1998) MolConnZ, version 3.5; Hall Associates Consulting.
77. Carhart R.E., Smith D.H., Venkataraghavan R. (1985) J. Chem. Inf. Comput. Sci., 25, 64-73.
78. Korolev D., Balakin K.V., Nikolsky Y., Kirillov E., Ivanenkov Y.A., Savchuk N.P., Ivashchenko A.A., Nikolskaya T. (2003) J. Med. Chem., 46, 3631-3643.
79. Kohonen T. (1989) Self-Organization and Associative Memory, 3rd edition, Springer-Verlag, Berlin.
80. Bugrim A., Nikolskaya T., Nikolsky Y. (2004) Drug Discov. Today, 9(3), 127-135.
81. Korzekwa K.R., Jones J.P., Gillette J.R. (1990) J. Am. Chem. Soc., 112, 7042-7046.
82. Harris J.W., Jones J.P., Martin J.L., LaRosa A.C., Olson M.J., Pohl L.R., Anders M.W. (1992) Chem. Res. Toxicol., 5, 720-725.
83. Yin H., Anders M.W., Korzekwa K.R., Higgins L., Thummel K.E., Kharasch E.D., Jones J.P. (1995) Proc. Nat. Acad Sci., 92, 11076-11080.
84. Grogan J., DeVito S.C., Pearlman R.S., Korzekwa K.R. (1992) Chem. Res. Toxicol., 5, 548-552.
85. Jones J.P., Mysinger M., Korzekwa K.R. (2002) Drug Metab. Dispos., 30, 7-12.
86. Jones J.P., Korzekwa K.R. (1996) Methods Enzymol., 272, 326-335.
87. Ortiz de Montellano P.R. (1999) in: Handbook of Drug Metabolism: The Cytochrome P450 Oxidative System (T.F. Woolf ed.) Dekker, New York, Chapter 4, pp. 109-130.
88. Omura T. (1999) Biochem. Biophys. Res. Commun., 266, 690-698.
89. Korzekwa K.R., Jones J.P., Higgins L.A. (2003) US Pat. 6,643,591. Der. Abstr., C2000, 224032.
90. Korzekwa K.R., Jones J.P. (2003) US Pat. 6,625,547. Der. Abstr., C2000, 224032.
91. Singh S.B., Shen L.Q., Walker M.J., Sheridan R.P. (2003) J. Med. Chem., 46, 1330-1336.
92. Higgins L., Korzekwa K.R., Rao S., Shou M., Jones J.P. (2001) Arch. Biochem. Biophys., 385, 220-230.
93. Smith D.A., Ackland M.J., Jones B.C. (1997) Drug Discov. Today, 2, 479-486.
94. Szklarz G.D., Halpert J.R. (1997) Life Sci., 61, 2507-2520.
95. Lightfoot T., Ellis S.W., Mahling J., Ackland M.J., Blaney F.E., Bijloo G.J., de Groot M.J., Vermeulen N.P., Blackburn G.M., Lennard M.S., Tucker G.T. (2000) Xenobiotica, 30, 219-233.
96. Rao S., Raoyama M., Schrag W.F., Trager A., Rettie., Jones J.P. (2000) J. Med. Chem., 43, 2789-2796.
97. Long A., Walker J.D. (2003) Environ. Toxicol. Chem., 22(8), 1894-1899.
98. Xue L.L., Wang H.F., Wang Q.M., Szklarz G.D., Domanski T.L., Halpert J.R., Correia M.A. (2001) Chem. Res. Toxicol., 14, 483-491.
99. de Groot M.J., Ackland M.J., Horne V.A., Alex A.A., Jones B.C. (1999) J. Med. Chem., 42, 1515-1524.
100. SYBYL (1997) version 6.4, Tripos Inc., http://www.tripos.com.
101. Zamora I., Afzelius L., Cruciani G. (2003) J. Med. Chem., 46, 2313-2324.
102. Goodford P.J.A. (1985) J. Med. Chem., 28, 849-857.
103. GRID V.20 (2001) Molecular Discovery Ld, (http://www.moldiscovery.com).
104. Ridderstrom M., Zamora I., Fjellstrom O., Andersson T.B. (2001) J. Med. Chem., 44(24), 4072-4081.
105. Pastor M., Cruciani G., McLay I., Pickett S., Clementi S. (2000) J. Med. Chem., 43(17), 3233-3243.
106. Park J.-Y., Harris D. (2003) J. Med. Chem., 46, 1645-1660.
107. Hansch C. (1972) Drug Metab. Rev., 1, 1-14.
108. Hansch C., Lien E.J., Helmer F. (1968) Arch. Biochem. Biophys., 128, 319-330.
109. Lewis D.F. (2000) Biochem. Pharmacol., 60, 293-306.
110. Lewis D.F., Modi S., Dickins M. (2002) Drug Metab. Rev., 34, 69-82.
111. Balakin K.V., Ekins S., Bugrim A., Ivanenkov Y.A., Korolev D., Nikolsky Y.V., Ivashchenko A.A., Savchuk N.P., Nikolskaya T. (2004) Drug Metab. Dispos., in press.
112. De Rienzo F., Fanelli F., Menziani M.C., De Benedetti P.G. (2000) J. Comp.-Aid. Mol. Des., 14, 93-116.
113. Jones J.P., He M., Trager W.F., Rettie A.E. (1996) Drug Metab. Dispos., 24, 1-6.
114. Strobl G.R., von Kruedener S., Stockigt J., Guengerich F.P., Wolff T. (1993) J. Med. Chem., 36, 1136-1145.
115. de Groot M.J., Ackland M.J., Horne V.A., Alex A.A., Jones B.C. (1999) J. Med. Chem., 42, 4062-4070.
116. Talele T.T., Kulkarni V.M. (1999) J. Chem. Inf. Comput. Sci., 39, 204-210.
117. Lee H., Yeom H., Kim Y.G., Yoon C.N., Jin C., Choi J.S., Kim B.-R., Kim D.-H. (1998) Biochem. Pharmacol., 55, 1369-1375.
118. Ekins S., Bravi G., Ring B.J., Gillespie T.A., Gillespie J.S., VandenBranden M., Wrighton S.A., Wikel J.H. (1999) J. Pharmacol. Exp. Ther., 288, 21-29.
119. Jones B.C., Hawksworth G., Horne V.A., Newlands A., Morsman J., Tute M.S., Smith D.A. (1996) Drug Metab. Dispos., 24, 260-266.
120. Mancy A., Broto P., Dijols S., Dansette P.M., Mansuy D. (1995) Biochemistry, 34, 10365-10375.
121. Mancy A., Dijols S., Poli S., Guengerich P., Mansuy D. (1996) Biochemistry, 35, 16205-16212.
122. Ekins S., Bravi G., Binkley S., Gillespie J.S., Ring B.J., Wikel J.H., Wrighton S.A. (2000) Drug Met. Dispos., 28, 994-1002.
123. Islam S.A., Wolf C.R., Lennard M.S., Sternberg J.E. (1991) Carcinogenesis, 12, 2211-2219.
124. Ekins S., Bravi G., Binkley S., Gillespie J.S., Ring B.J., Wikel J.H., Wrighton S.A. (1999) Pharmacogenetics, 9, 477-489.
125. Lewis D.F., Eddershaw P.J., Goldfarb P.S., Tarbit M.H. (1996) Xenobiotica, 10, 1067-1086.
126. Ekins S., Bravi G., Wikel J.H., Wrighton S.A. (1999) J. Pharmacol. Exp. Ther., 291, 424-433.
127. Ekins S., Bravi G., Binkley S., Gillespie J.S., Ring B.J., Wikel J.H., Wrighton S.A. (1999) J. Pharmacol. Exp. Ther., 290, 429-438.
128. Ekins S., de Groot M., Jones J.P. (2001) Drug Metab. Dispos., 29, 936-944.
129. Smith D.A., Ackland M.J., Jones B.C. (1997) Drug Discov. Today, 2, 406-414.
130. de Groot M.J., Ekins S. (2002) Adv. Drug Deliv. Rev., 54, 367-383.
131. Afzelius L., Zamora I., Masimirembwa C.M., Karlen A., Andersson T.B., Mecucci S., Baroni M., Cruciani G. (2004) J. Med. Chem., 47(4), 907-914.
132. Afzelius L., Masimirembwa C.M., Karlen A., Andersson T.B., Zamora I. (2002) J. Comput. Aided. Mol. Des., 16(7), 443-458.
133. Afzelius L., Zamora I., Ridderstrom M., Andersson T.B., Karlen A., Masimirembwa C.M. (2001) Mol. Pharm., 59(4), 909-919.
134. de Groot M.J., Vermeulen N.P.E. (1997) Drug Metab. Rev., 29, 747-799.
135. Miners J.O., Smith P.A., Sorich M.J., McKinnon R.A., Mackenzie P.I. (2004) Ann. Rev. Pharm., 44, 1-25.
136. Sorich M.J., McKinnon R.A., Miners J.O., Smith P.A. (2003) J. Chem. Inf. Comput. Sci., 43, 2019-2024.
137. Buchwald P., Bodor N. (1999) J. Med. Chem., 42, 5160-5168.
138. Sorich M.J., Smith P.A., McKinnon R.A., Miners J.O. (2002) Pharmacogenetics, 12(8), 635-645.
139. Smith P.A., McKinnon R.A., Sorich M.J., Miners J.O. (2002) J. Med. Chem., 46(9), 1617-1626.
140. Sprague P.W., Hoffmann R. (1997) in: Computer Assisted Lead Finding and Optimization Current Tools for Medicinal Chemistry: Catalyst Pharmacophore Models and their Utility as Queries for Searching 3D Databases (H.van de Waterbeemd, B. Testa and G. Folkers eds.) VHCA, Basel, pp. 233-240.
141. Balakin K.V., Ekins S., Bugrim A., Ivanenkov I.A., Korolev D., Nikolsky Y.V., Skorenko A.V., Ivashchenko A.A., Savchuk N.P., Nikolskaya T. (2004) Drug Metab. Dispos., in press.
142. Borodina Y., Sadym A., Filimonov D., Blinova V., Dmitriev A., Poroikov V.V. (2003) J. Chem. Inf. Comput. Sci., 43(5), 1636-1646.
143. Poroikov V.V., Filimonov D.A., Borodina Yu. V., Lagunin A.A., Kos A. (2000). J. Chem. Inform. Comput. Sci., 40(6), 1349-1355.
144. Poroikov V.V., Filimonov D.A. (2002). J. Comput. Aid. Molec. Des., 16(11), 819-824.
145. Stepanchikova A.V., Lagunin A.A., Filimonov D.A., Poroikov V.V. (2003). Current Med. Chem., 10(3), 225-233.
146. Jacoby E., Schuffenhauer A., Floersheim P. (2003) Drug News Perspect., 16, 93-102.
147. Lisitsa A.V., Gusev S.A., Karuzina I.I., Archakov A.I., Koymans L. (2001) SAR QSAR Environ. Res., 12(4), 359-366.
148. Ellis L.B., Hershberger C.D., Wackett L.P. (1999) Nucl. Acids Res., 27(1), 373-376.
149. Selkov E., Jr., Grechkin, Y., Mikhailova N., Selkov E. (1998) Nucl. Acids Res., 26(1), 43-45.